🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Improving the quality of life and achieving Treatment-Free Remission(TFR) i...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2022-07-31
Trial ID
NCT05440747
Treatments Being Tested
Ropeginterferon is a long-acting next-generation mono-pegylated interferon ...
Status
Completed
Location
Eulji University Hospital
Start Date
2021-11-30
Trial ID
NCT07105319
Treatments Being Tested
The purpose of this study is to determine if adding Ruxolitinib to a Tyrone...
Status
Active Not Recruiting
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2019-11-19
Trial ID
NCT03610971
Treatments Being Tested
This study aimed to assess the optimal duration of nilotinib 300 mg twice d...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-04-15
Trial ID
NCT01743989
Treatments Being Tested
The aim of this study is to establish if consolidation of imatinib-treated ...
Status
Terminated
Location
Hôpital Maisonneuve-Rosemont (CIUSSS EMTL)
Start Date
2023-11-01
Trial ID
NCT05413915
This phase II trial studies how stopping tyrosine kinase inhibitors will af...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2019-11-08
Trial ID
NCT03817398
The investigator propose an extension of the previous National, multicentri...
Status
Recruiting
Location
Division of Hematology-AO Mauriziano Hospital, University of Turin
Start Date
2021-08-09
Trial ID
NCT04769947
To evaluate molecular relapse free rates 6 months after stopping nilotinib ...
Status
Completed
Location
University of Alabama Comprehensive Cancer Center University of Alabama (8)
Start Date
2013-08-12
Trial ID
NCT01744665
Treatments Being Tested
This is a single arm phase II study that will enroll a minimum of 47 subjec...
Status
Recruiting
Location
The Barbara Ann Karmanos Cancer Institute
Start Date
2021-11-11
Trial ID
NCT04838041
Treatments Being Tested
Ponatinib has shown to induce deeper molecular responses compared with imat...
Status
Unknown
Location
Hospital Trials i Pujol
Start Date
2019-04-30
Trial ID
NCT04043676
Treatments Being Tested